Hulspharma SA
1.0 FTEThe score of Hulspharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +8 % Total assets +4 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 12 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Hulspharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 133,452 € | ||||
| Equity | 889,981 € | ||||
| Cash | 406,359 € | ||||
| EBITDA | 179,542 € | ||||
| Total assets | €1.20m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 31 Oct 2023
- Year ended 31 Dec 2021filed on 30 Sep 2022
Hulspharma's financial analysis
- Solvency74.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Hulspharma
Hulspharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0435.910.080
- VAT number
- BE0435910080
- Peppol
- Registered · 0208:0435910080 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 30 Nov 1988
- Registered office
- 2235 Hulshout
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Hulspharma (SA) has been based in Hulshout since 1988, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 133,452 € and equity of 889,981 €; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 74.0%, above the median of its sector (44.2%).
Companies similar to Hulspharma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek WAEGHE - VAN GELUWE DE BERLAERE Retail sale of pharmaceutical products Nazareth-De Pinte · balance sheet €1.20m
- Hingiphar Retail sale of pharmaceutical products Kampenhout · balance sheet €1.20m
- Pharmacie Rouard Retail sale of pharmaceutical products Brussels · balance sheet €1.21m
- Jolypharma Retail sale of pharmaceutical products Riemst · balance sheet €1.20m
- Diximo Retail sale of pharmaceutical products Ferrières · balance sheet €1.20m
- Dalemans Retail sale of pharmaceutical products Buggenhout · balance sheet €1.20m
- Pharmabrussels Flagey Retail sale of pharmaceutical products Ixelles · balance sheet €1.20m
- Aa.Pharma Turnhout Retail sale of pharmaceutical products Turnhout · balance sheet €1.21m
Frequently asked questions about Hulspharma
What is the revenue of Hulspharma?
Hulspharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Hulspharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0435910080 for Hulspharma, if the company is VAT-registered. Its company number (CBE) is 0435.910.080.
Where is the registered office of Hulspharma?
According to the CBE register, the registered office of Hulspharma is in 2235 Hulshout.
What is the equity of Hulspharma?
At the close of the 2025 financial year, the equity of Hulspharma amounts to 889,981 €, a solvency of 74.0% of total assets.
How many people work at Hulspharma?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Hulspharma?
The register lists 2 active mandates at Hulspharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Hulspharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →